FDA Petition-Shaming Plan Gives Ammo To Antitrust Suits
The U.S. Food and Drug Administration appears poised to shame branded-drug makers that make strategically timed objections to generic-drug approval standards, providing new ammunition for antitrust suits over delayed access to...To view the full article, register now.
Already a subscriber? Click here to view full article